NCT07593092
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07593092
Title Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Xencor, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Xencor Investigative Site RECRUITING Lake Success New York 11042 United States Details
Xencor Investigative Site RECRUITING New York New York 10029 United States Details
Xencor Investigative Site RECRUITING The Bronx New York 10461 United States Details
Xencor Investigative Site RECRUITING Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field